On air · 1 of 3 networks
Zeus
- zeusinc.com
- US
- 1,428 employees
Zeus’s ads on LinkedIn, Meta and Google, recorded by adsrunning. Browse the latest here for free. Sign up free to see all 718. Watch Zeus with Starter to get each new one in your feed.
Watchlist with Starter · $49/mo
| Network | Status | Live ads | Nov 2025LinkedIn activity · 52 weeksOct 2026 | Checked | Next step |
|---|---|---|---|---|---|
| Running | 112 | Checked 30 Oct 2026 | See all 718 ads → | ||
| Meta | Not checked | — | |||
| Recently | 100+ | Ads on the Google Ads Transparency Center | Checked 16 Oct 2026 | Collect them with the API → |
Zeus has 112 live LinkedIn ads. We recorded 100+ Google ads on 16 Oct 2026.
Latest ads
- LINKEDIN · IMAGESince 22 Oct 2026
First-generation bioresorbable vascular scaffolds suffered from fundamental limitations regarding strut thickness, limited over-expansion, and the requirement for special considerations in implantation techniques. By studying the failures and building on past successes, Zeus has developed Absorv™ XSE, an optimized polymer tubing platform specifically designed for bioresorbable scaffolds (BRS). Read this whitepaper to learn more about this journey, and how this product can help pave the way for next-generation therapies and improved patient outcomes.
- LINKEDIN · IMAGESince 22 Oct 2026
If you’re a device designer interested in stent technology and bioresorbable vascular scaffolds, read this whitepaper, which covers: ✔️ Limitations of metallic stents for treating CAD & PAD and challenges associated with first gen bioresorbable vascular scaffolds in the past ✔️ Generational advancements in stent technology ✔️ Results from industry testing of Absorv™ XSE, an optimized polymer tubing platform which has been specifically designed to overcome previous challenges with BRS
- LINKEDIN · IMAGESince 21 Oct 2026
First-generation bioresorbable vascular scaffolds suffered from fundamental limitations regarding strut thickness, limited over-expansion, and the requirement for special considerations in implantation techniques. By studying the failures and building on past successes, Zeus has developed Absorv™ XSE, an optimized polymer tubing platform specifically designed for bioresorbable scaffolds (BRS). Read this whitepaper to learn more about this journey, and how this product can help pave the way for next-generation therapies and improved patient outcomes ⬇
- LINKEDIN · IMAGESince 21 Oct 2026
If you’re a device designer interested in stent technology and bioresorbable vascular scaffolds, read this whitepaper, which covers: ➡ Limitations of metallic stents for treating CAD & PAD and challenges associated with first gen bioresorbable vascular scaffolds in the past ➡ Generational advancements in stent technology ➡ Results from industry testing of Absorv™ XSE, an optimized polymer tubing platform which has been specifically designed to overcome previous challenges with BRS
- LINKEDIN · IMAGESince 6 Oct 2026
PFX Flex™ Sub-Lite-Wall PFAS-free catheter liners offer exceptional abrasion resistance, helping to minimize particulate generation in catheter assemblies. Read this test report to see how PFX Flex™ compares to traditional PTFE liners in abrasion resistance and other key performance areas including lubricity, flexibility, and bond strength.
- LINKEDIN · IMAGESince 6 Oct 2026
The abrasion-resistant construction of these PFAS-free catheter liners resists scratching, scuffing, and flaking, for reliability in applications where particulate sensitivity is critical. Examine abrasion resistance performance alongside other key properties in this PFX Flex™ vs PTFE test report.
6 of 718 adsSign up to see every Zeus ad, filter by format and date, and get alerts on new ones.
See all 718 adsWatch the companies you care about.
Filter every ad by industry, country, format and network, and get alerts when a company you watch starts running new ads.